MX2009004554A - Metodos discontinuos de tratamiento de cancer. - Google Patents

Metodos discontinuos de tratamiento de cancer.

Info

Publication number
MX2009004554A
MX2009004554A MX2009004554A MX2009004554A MX2009004554A MX 2009004554 A MX2009004554 A MX 2009004554A MX 2009004554 A MX2009004554 A MX 2009004554A MX 2009004554 A MX2009004554 A MX 2009004554A MX 2009004554 A MX2009004554 A MX 2009004554A
Authority
MX
Mexico
Prior art keywords
treating cancer
discontinuous methods
methods
discontinuous
taxane
Prior art date
Application number
MX2009004554A
Other languages
English (en)
Inventor
Paul Kirschmeier
Brian Long
Susan Arbuck
Genevieve A Menard
Siu-Iong Yao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2009004554A publication Critical patent/MX2009004554A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos de tratamiento de tumores sensibles a taxano (es decir, cánceres tratables con taxano) usando un taxano y la dosificación discontinua de lonafarnib.
MX2009004554A 2006-10-25 2007-10-23 Metodos discontinuos de tratamiento de cancer. MX2009004554A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85434306P 2006-10-25 2006-10-25
US86020606P 2006-11-20 2006-11-20
PCT/US2007/022462 WO2008051531A2 (en) 2006-10-25 2007-10-23 Discontinuous methods of treating cancer

Publications (1)

Publication Number Publication Date
MX2009004554A true MX2009004554A (es) 2009-05-11

Family

ID=39156324

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004554A MX2009004554A (es) 2006-10-25 2007-10-23 Metodos discontinuos de tratamiento de cancer.

Country Status (8)

Country Link
US (1) US20100104661A1 (es)
EP (1) EP2076263A2 (es)
JP (1) JP2010507662A (es)
CA (1) CA2667363A1 (es)
CL (1) CL2007003056A1 (es)
MX (1) MX2009004554A (es)
TW (1) TW200824681A (es)
WO (1) WO2008051531A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2397558A1 (en) * 2000-02-24 2001-08-30 Janssen Pharmaceutica N.V. Dosing regimen
CN101181269A (zh) * 2001-11-30 2008-05-21 先灵公司 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用

Also Published As

Publication number Publication date
CL2007003056A1 (es) 2008-05-16
US20100104661A1 (en) 2010-04-29
WO2008051531A3 (en) 2008-06-19
TW200824681A (en) 2008-06-16
JP2010507662A (ja) 2010-03-11
WO2008051531A2 (en) 2008-05-02
EP2076263A2 (en) 2009-07-08
CA2667363A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
HK1217103A1 (zh) 二芳基乙內酰脲化合物
IL182423A0 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
EA201401096A1 (ru) Комбинационная терапия, включающая антигиалуронановый агент и таксан, направленный на раковую мишень
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
WO2007053573A3 (en) Treatment of cancer with sorafenib
MX2009006779A (es) Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana.
MX2010000465A (es) Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
TW200618808A (en) Methods for treating diverse cancers
TW200642684A (en) Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and taxanes
EP1942884A4 (en) METHOD FOR THE TREATMENT OF CANCER WITH SAHA, CARBOPLATIN AND PACLITAXEL AND OTHER COMBINATION THERAPIES
JO2833B1 (en) Amino pyrazole compound
MX2009005058A (es) Metodos para tratar, diagnosticar o detectar cancer.
TNSN08401A1 (en) Methods of treating diagnosing or detecting cancer
MX2010008994A (es) Combinacion que comprende paclitaxel para el tratamiento del cancer de ovario.
NZ589795A (en) Use of LM-1 antibody which binds to NONO/nmt55 protein to prevent metastasis
MX2009004554A (es) Metodos discontinuos de tratamiento de cancer.
MX2009004555A (es) Metodos de tratamiento de cancer de ovario.
TW200706536A (en) Indole compounds
ATE443138T1 (de) Hemmung der expression von spag9 mit sirnas
MX2009011041A (es) Metodos y composiciones para contribuir al tratamiento de canceres.
TN2009000491A1 (en) Use of heterosidic flavonoid derivatives for therapy of stem cell cancers